By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OptiNose AS 

Oslo Innovation Center
Gaustadalléen 21
Oslo    N-0349  Norway
Phone: 47-2295-8014 Fax: 47-2295-8098


SEARCH JOBS


Industry
Medical Device






Company News
OptiNose AS Expands Senior Management Team With Three Key Appointments In Core Business Areas Of Operations, Regulatory Affairs And Commercialization 6/12/2014 8:06:11 AM
OptiNose AS Presents Positive Results From Phase 3 COMPASS Study 6/10/2014 6:39:06 AM
OptiNose AS Announces FDA Acceptance Of New Drug Application For AVP-825 For The Acute Treatment Of Migraine 3/27/2014 9:21:30 AM
OptiNose AS to Present Data Highlighting New Migraine Treatment at International Headache Congress 6/28/2013 9:24:11 AM
OptiNose AS Announces First Patient Enrolled in Phase III Study of Sumatriptan Powder Delivered Intranasally with Innovative Bi-directional Device 2/9/2012 7:48:40 AM
OptiNose AS Files Investigational New Drug Application to use Sumatriptan Delivered with its Novel Drug Delivery Technology 2/3/2012 6:15:20 AM
OptiNose AS Selects BioClinica, Inc.'s Trident IWR, Optimizer and Imaging Core Lab Solutions 9/8/2011 10:00:56 AM
OptiNose AS Standardizes on Medidata Solutions, Inc. Rave Clinical Technology 8/30/2011 10:44:43 AM
OptiNose AS Bi-Directional Drug Delivery Technology Wins Innovation Award for Potential Benefits of Nose to Brain Application 5/23/2011 11:07:18 AM
OptiNose AS Receives Nearly $489,000 Grant Award under U.S. Government Qualifying Therapeutic Discovery Project Program 11/3/2010 11:43:30 AM
12
//-->